C

Clinical Partners, LLC | Johnston, RI

Research site
(Unclaimed)
Location
1524 Atwood Avenue, Suite 330, Johnston, Rhode Island, United States of America
Site insights

Top conditions

Psoriasis (17 trials)

Eczema (16 trials)

Atopic Dermatitis (16 trials)

Dermatitis (16 trials)

Acne Vulgaris (7 trials)

Top treatments

Lebrikizumab
Peramivir
BI 730357
CP-690,550
Apremilast
CB-03-01
Pf-04965842
Clobetasol Propionate
CC-10004
LY3009104

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

5 of 47
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab (ADapt)

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) pre...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Other: Placebo
Drug: PF-07264660

This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...

Enrolling
Atopic Dermatitis
Drug: ADX-914
Drug: Placebo

This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.

Active, not recruiting
Atopic Dermatitis
Biological: Lebrikizumab

This is a parallel, Phase 2, 2-arm, double-blind, randomized, multicenter, multinational, placebo-controlled study to evaluate efficacy, safety, phar...

Enrolling
Hidradenitis
Drug: Amlitelimab
Drug: Placebo

Trial sponsors

Lilly logo

Lilly (8 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems